Clinical Features and Treatment Outcomes of 51 Patients with Chronic Myeloid Leukemia Treated with a Tyrosine Kinase Inhibitor at a Single Institution from 2002 to 2014

Although clinical trials of first- and second-generation tyrosine kinase inhibitors (TKIs) have been shown to improve the prognosis of chronic myeloid leukemia (CML), there is still uncertainty about the clinical features, treatment outcomes, adverse effects, and other possible problems of their use...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Exp Hematop
Main Authors: Kawano, Noriaki, Yoshida, Shuro, Kawano, Sayaka, Kuriyama, Takuro, Yamashita, Kiyoshi, Ochiai, Hidenobu, Shimoda, Kazuya, Ishikawa, Fumihiko, Ueda, Akira, Kikuchi, Ikuo
Formato: Artigo
Idioma:Inglês
Publicado: JSLRT 2016
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144279/
https://ncbi.nlm.nih.gov/pubmed/27334856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3960/jslrt.56.34
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares